Renaissance Group’s Zepp Health ZEPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-17,783
Closed -$571K 277
2021
Q3
$571K Buy
17,783
+1,647
+10% +$68K 0.02% 222
2021
Q2
$758K Buy
16,136
+7,329
+83% +$305K 0.03% 190
2021
Q1
$379K Buy
8,807
+38
+0.4% +$2.21K 0.02% 231
2020
Q4
$416K Sell
8,769
-243
-3% -$12.1K 0.02% 224
2020
Q3
$463K Sell
9,012
-143
-2% -$7.85K 0.02% 202
2020
Q2
$453K Sell
9,155
-4,787
-34% -$221K 0.02% 198
2020
Q1
$732K Sell
13,942
-4,787
-26% -$259K 0.04% 132
2019
Q4
$900K Sell
18,729
-284
-1% -$11.9K 0.04% 135
2019
Q3
$761K Buy
19,013
+49
+0.3% +$2.06K 0.03% 146
2019
Q2
$759K Buy
18,964
+8,670
+84% +$362K 0.03% 148
2019
Q1
$539K Sell
10,294
-5,835
-36% -$315K 0.02% 196
2018
Q4
$634K Buy
+16,129
New +$634K 0.03% 157

Other funds holding ZEPP

Renaissance Group's ZEPP Position: Q4 2021 in Review

Renaissance Group sold out of Zepp Health (ZEPP) in Q4 2021, closing a stake of 17,783 shares — an estimated $571K sold.

Renaissance Group first reported a position in ZEPP in Q4 2018 and held it in 12 quarters. The position peaked at $900K in Q4 2019. 53 funds tracked by Wall St. Rank hold ZEPP as of Q4 2021.

  • Renaissance Group reported no remaining Zepp Health position as of Q4 2021 after selling out during the quarter.
  • Renaissance Group sold 17,783 Zepp Health shares in Q4 2021, an estimated $571K.
  • Renaissance Group first reported a position in Zepp Health in Q4 2018 and held it in 12 quarters.
  • Renaissance Group's Zepp Health position peaked at $900K in Q4 2019.
  • 53 funds tracked by Wall St. Rank held Zepp Health as of Q4 2021.

Based on Renaissance Group's 13F filing for Q4 2021, filed 11 Feb 2022.